Rakesh, Gopalkumar http://orcid.org/0000-0002-7134-2804
Morey, Rajendra A.
Zannas, Anthony S.
Malik, Zainab
Marx, Christine E.
Clausen, Ashley N.
Kritzer, Michael D.
Szabo, Steven T.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (5R01NS086885)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (5R01MH111671)
U.S. Department of Veterans Affairs (5I01CX000748, 5I01CX001277, 1I01CX001569, 1IK2CX001397-01A2)
Article History
Received: 26 April 2017
Revised: 24 January 2019
Accepted: 14 February 2019
First Online: 13 March 2019
Compliance with ethical standards
:
: STS has served on the advisory board for Jazz Pharmaceuticals, and as a consultant speaker for Neurocrine Biosciences, Teva Pharmaceutical Industries Ltd, and Otsuka/Lundbeck Pharmaceuticals. CEM is a co-applicant on pending patents focusing on neurosteroids in CNS disorders (no patents issued; no licensing in place; VA 208 waiver in place). All the remaining authors declare that they have no conflict of interest.